Collegium Pharmaceutical Inc (COLL)
32.20
-2.52
(-7.26%)
USD |
NASDAQ |
Nov 08, 16:00
32.20
0.00 (0.00%)
After-Hours: 17:20
Collegium Pharmaceutical Revenue (TTM): 576.65M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 576.65M |
| March 31, 2024 | 566.92M |
| December 31, 2023 | 566.77M |
| September 30, 2023 | 546.64M |
| June 30, 2023 | 536.95M |
| March 31, 2023 | 524.95M |
| December 31, 2022 | 463.93M |
| September 30, 2022 | 361.68M |
| June 30, 2022 | 313.50M |
| March 31, 2022 | 272.90M |
| December 31, 2021 | 276.87M |
| September 30, 2021 | 325.78M |
| June 30, 2021 | 326.11M |
| March 31, 2021 | 321.23M |
| December 31, 2020 | 310.02M |
| Date | Value |
|---|---|
| September 30, 2020 | 307.95M |
| June 30, 2020 | 301.71M |
| March 31, 2020 | 298.70M |
| December 31, 2019 | 296.70M |
| September 30, 2019 | 295.92M |
| June 30, 2019 | 293.16M |
| March 31, 2019 | 291.18M |
| December 31, 2018 | 280.41M |
| September 30, 2018 | 217.78M |
| June 30, 2018 | 159.55M |
| March 31, 2018 | 90.05M |
| December 31, 2017 | 28.48M |
| September 30, 2017 | 18.98M |
| June 30, 2017 | 7.443M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
272.90M
Minimum
Mar 2022
576.65M
Maximum
Jun 2024
394.52M
Average
325.78M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Rigel Pharmaceuticals Inc | 130.30M |
| Esperion Therapeutics Inc | 277.79M |
| Context Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 12.02M |
| Palatin Technologies Inc | -- |